% | $
Quotes you view appear here for quick access.

Cambrex Corporation. Message Board

  • longfcel longfcel Feb 15, 2013 3:35 AM Flag

    Dow Chemical and Cambrex Collaborate to Manufacture Drug-Solubility Solution

    First off, I'm asking if there is still some little fish on this stock, due to the fact big holders are 91+% and this YMB has no message since weeks.
    I'll try.

    On behalf of the above news, what are you insight?
    I think is obviously a positive news... it increases CBM's revenues, but that's starting from 2013 year end, because I read the facility is under construction.

    Reading the last 10-k we have a declared amount of expeditures for 2013 similar to 2012 year's.
    I don't know how to read the news.
    The fact is..... still huge big holders %..... still good cash in bank.
    Who thinks there could be a buyout on CBM?
    Who thinks there could be a secondary because of this facility?

    That's the dilemma.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Sorry, a little of confusion.

      "For 2013, capital expenditures are expected to be approximately $36,000 to $40,000. The increase in capital expenditures versus prior year is primarily driven by a previously announced expansion of the Company’s large scale manufacturing capacity to support expected growth in the business and an agreement signed during 2012 to provide large Phase III and commercial launch materials for a customer. "
      And this is due to the new faclity in Karlskoga AB (involved in the agreement).

      "Cash flows used in investing activities in 2012 of ***** $20,182***** mainly reflects capital expenditures of $18,156 and advances to partially-owned affiliates of $2,047".

      I'm not an expert in these kind of things. My question is:
      as CBM has a "$250 Mil revolving credit facility of which $64 Mil was outstanding that expires in November 2016"., does this credit avert a secondary offering for sometime?

48.88+0.19(+0.39%)May 5 4:02 PMEDT